Choose any audiobook from over 180,000 titles... yours to keep with a free trial.
Search Suggestions
To save themselves, pharmaceutical companies will have to break up their giant R&D organizations, and put passionate scientists back in charge. From the May 2008 issue of Harvard Business Review.
MoreWe've sent an email with your order details. Order ID #:
Listen on the Audible app or these devices.
Launch Audible App-or-
Download Free Audible AppTo access this title, visit your library in the app or on the desktop website.
Listen on the Audible app or these devices.
Launch Audible App-or-
Download Free Audible AppAudible does not currently have the rights to sell this title in your country.
Please consider another book.
Continue BrowsingPlease add a payment method to continue.
Add a Payment MethodPlease edit your payment details or add a new card.
If the problem persists, contact customer service at (888) 283-5051
Review My Payment MethodIf the problem persists, contact customer service at (888) 283-5051
Please select a default credit card to continue.
Select Credit CardIt looks like you've already used the specified payment method for a free trial.
Please contact customer service if you think we have made a mistake. (888) 283-5051
Start Your $14.95 MembershipIf the problem persists, contact customer service at (888) 283-5051
If the problem persists, contact customer service at (888) 283-5051
%22 by Jean-Pierre Garnier, narrated by Todd Mundt.
)
Interesting thoughts about R&D in Big Pharma
- Gvido
